Key result
Cardiac rehab in HF linked to greater NT-proBNP reductions in moderate-severe versus mild-moderate functional limitation.
Why the study?
The study aimed to evaluate the impact of 6 months of cardiac rehabilitation on biological markers, functional status, and prognostic echocardiographic deformation parameters in heart failure.
Does a 12-week cardiac rehabilitation program improve echocardiographic deformation parameters, functional status, and biomarkers in patients with heart failure?
Population
100 patients with HF admitted to a specialized cardiac rehabilitation center
Comparison
Moderate-severe (n=37) vs mild-moderate functional limitation (n=63)
Design
Prospective cohort study
Follow-up
6 months
Authors
Loading...
CR may improve filling pressures and function in HF; hypothesis-generating, requiring RCTs before any practice change.
Cohort (n=100)
No
Does a 12-week cardiac rehabilitation program improve echocardiographic deformation parameters, functional status, and biomarkers in patients with heart failure?
Absolute Event Rate: -61.22% vs -49.25%
p-value: p=0.024
A 12-week cardiac rehabilitation program significantly improves echocardiographic deformation parameters and biomarkers in heart failure patients, particularly those with more severe baseline functional limitations.
Adam et al. (2026) conducted a cohort in Heart failure (n=100). Moderate-severe functional limitation (undergoing cardiac rehabilitation) vs. Mild-moderate functional limitation was evaluated on Change in NT-proBNP levels (pg/ml) (p=0.024). Cardiac rehabilitation in heart failure patients yielded greater NT-proBNP reductions in those with moderate-severe versus mild-moderate functional limitation (-61.22 vs -49.25 pg/ml; P=0.024).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: